HC Wainwright & Co. Downgrades Timber Pharmaceuticals to Neutral
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Raghuram Selvaraju has downgraded Timber Pharmaceuticals from Buy to Neutral.
August 28, 2023 | 10:14 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Timber Pharmaceuticals has been downgraded from Buy to Neutral by HC Wainwright & Co.
The downgrade from Buy to Neutral by a prominent analyst could potentially lead to a decrease in investor confidence, which may negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100